Anti‐dyslipidemic effects of Pueraria lobata root and Glycine max (L.) Merrill extracts fermented with Lactiplantibacillus plantarum in ovariectomized mice

Abstract

AbstractPueraria lobata root and Glycine max (L.) Merrill are rich in phytoestrogens. However, these bioactive ingredients have limited bioavailability due to their high molecular weight. In this study, we extracted two natural products and fermented with Lactiplantibacillus plantarum before mixing the fermented extracts (FPE‐FGE). To understand whether FPE‐FGE could alleviate menopause with dyslipidemia, we examined their effects on ovariectomy (OVX)‐induced dyslipidemia in mice. Oral administration of the FPE‐FGE (1:9, 3:7, and 9:1) did not affect safety‐related biomarkers, such as uterus index (%), vagina index (%), aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine. Furthermore, FPE‐FGE (1:9, 3:7, and 9:1) increased the levels of 17β‐estradiol (E2) and expression of uterus estrogen receptor β (ERβ); there was little effect on the expression of uterus estrogen receptor α (ERα), and reduced the levels of gonadotropins, such as luteinizing hormone (LH) and follicle‐stimulating hormone (FSH). However, only the FPE‐FGE (3:7) reduced the levels of blood lipids, including total cholesterol (TC) and LDL‐cholesterol (LDL‐C). Accordingly, FPE‐FGE (3:7) upregulated endothelial nitric oxide synthase (eNOS), nitric oxide (NO), cyclic guanosine monophosphate (cGMP), and protein kinase G (PKG). In conclusion, FPE‐FGE (3:7) attenuated the menopausal dyslipidemia by upregulating eNOS‐NO‐cGMP signaling pathway.